Track the 株式会社ペルセウスプロテオミクス share price and the full management transaction log of the company, a listed issuer based in Japan. Shares trade on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社ペルセウスプロテオミクス has published 40 public disclosures. Market capitalisation: €2.4bn. The latest transaction was filed on 3 July 2026 (Holding update). Among the most active insiders: SBI SECURITIES Co.,Ltd.. Every trade is openly available.
40
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,348 of 28,257 companies
28.7
score / 100
Value
8
Quality
50
FCF yld-27%
Earn yld-30%
EV/EBITDA·
ROE-54%
Gross mgn86%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Perseus Proteomics Co., Ltd. is a company specializing in proteomics, providing innovative solutions for health and pharmaceutical research. It is listed on the XTKS market.